Weight loss drug "money printing machine" in full swing! Eli Lilly's (LLY.US) total mergers and acquisitions amount has exceeded 20 billion US dollars this year, fully betting on the fields of cancer, gene therapy, and vaccines.

Zh tng cijng APP hxn, pngchng jinfi yo di li de j' xinjnli, l li (LLY.US) zhngzi xin q gngs lsh shng gum zud de bngmi kungcho. Shj xinsh, l li 2026 nin yli y xunb chogu 200 y miyun de shugu y hzu jioy, chungxi gngs nind bngmi jn' lsh xngo. Shngsh jn' hi boku hux lchng fkun. According to the Zh tng cijng APP, fueled by the massive cash flow brought by weight loss drugs, Lilly (LLY.US) is currently unleashing the largest merger and acquisition frenzy in the company's history. Data shows that Lilly has announced over $20 billion in acquisitions and partnership deals since 2026, setting a new record for the company's annual merger and acquisition amount. The above amount also includes subsequent milestone payments.